Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Frega

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 13, 2020
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experienceGiovanni Brandi, Alessandro Rizzo, Filippo Gustavo Dall'Olio, et al.
Skeletal Radiology|October 11, 2025
A proposed radiological model for preoperative chemotherapy response prediction in patients with skeletal Ewing sarcomaHisaki Aiba, Paolo Spinnato, Ayano Aso, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|June 17, 2025
Comparison of histological response across patients with Ewing sarcoma treated with preoperative chemotherapy with or without preoperative radiotherapyHisaki Aiba, Ayano Aso, Alberto Righi, et al.
Cancers|January 10, 2026
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center ExperienceAlessandro Parra, Emanuela Palmerini, Maria Antonella Laginestra, et al.
Frontiers in Oncology|October 25, 2023
NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case reportEmanuela Palmerini, Giorgio Frega, Marco Gambarotti, et al.
Skeletal Radiology|May 7, 2024
A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcomaAyano Aso, Hisaki Aiba, Matteo Traversari, et al.
Scientific Reports|September 14, 2017
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantationMatteo Ravaioli, Alessandro Cucchetti, Antonio Daniele Pinna, et al.
Expert Review of Gastroenterology & Hepatology|December 10, 2021
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter studyMassimiliano Salati, Alessandro Rizzo, Valeria Merz, et al.
Medicina (Kaunas, Lithuania)|November 11, 2022
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World StudyAlessandro Rizzo, Massimiliano Salati, Giorgio Frega, et al.
The Oncologist|April 2, 2016
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma PatientsGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 13, 2020
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experienceGiovanni Brandi, Alessandro Rizzo, Filippo Gustavo Dall'Olio, et al.
Skeletal Radiology|October 11, 2025
A proposed radiological model for preoperative chemotherapy response prediction in patients with skeletal Ewing sarcomaHisaki Aiba, Paolo Spinnato, Ayano Aso, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|June 17, 2025
Comparison of histological response across patients with Ewing sarcoma treated with preoperative chemotherapy with or without preoperative radiotherapyHisaki Aiba, Ayano Aso, Alberto Righi, et al.
Cancers|January 10, 2026
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center ExperienceAlessandro Parra, Emanuela Palmerini, Maria Antonella Laginestra, et al.
Frontiers in Oncology|October 25, 2023
NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case reportEmanuela Palmerini, Giorgio Frega, Marco Gambarotti, et al.
Skeletal Radiology|May 7, 2024
A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcomaAyano Aso, Hisaki Aiba, Matteo Traversari, et al.
Scientific Reports|September 14, 2017
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantationMatteo Ravaioli, Alessandro Cucchetti, Antonio Daniele Pinna, et al.
Expert Review of Gastroenterology & Hepatology|December 10, 2021
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter studyMassimiliano Salati, Alessandro Rizzo, Valeria Merz, et al.
Medicina (Kaunas, Lithuania)|November 11, 2022
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World StudyAlessandro Rizzo, Massimiliano Salati, Giorgio Frega, et al.
The Oncologist|April 2, 2016
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma PatientsGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Pageof 6